Variable | HR (95% CI) | P |
---|---|---|
Age (years) | Â | Â |
 ≥ 60 vs < 60 | 2.221 (1.667–2.961) |  < 0.001 |
Gender | Â | Â |
 Male vs female | 1.382 (1.034–1.848) | 0.029 |
LANCL2 gene status | Â | Â |
 Amplification vs no alteration | NA | 0.351 |
EGFR gene status | Â | Â |
 Amplification vs no alteration | NA | 0.799 |
LANCL2 and EGFR genes status | Â | Â |
 Co-amplification vs no alteration | NA | 0.553 |